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Abstract : N-3 fatty acids have been reported to be effective for asthma. In the 
present study, the effects of perilla seed oil (n-3 fatty acids) on asthma were compared 
with the effects of corn oil (n-6 fatty acids) in terms of pulmonary function, 
lipometabolism and the generation of leukotriene C4 (LTC4) by leucocytes. A total of 
28 asthmatic patients were randomly divided into two groups : Group A patients (15 
subjects) consumed perilla seed oil-rich supplementation, while Group B patients (13 
subjects) consumed corn oil-rich supplementation for 4 weeks. Generation of LTC4 by 
leucocytes, respiratory function and the serum levels of lipids were compared between 
the two groups. The generation of LTC4 by leucocytes decreased significantly in Group 
A subjects following perilla seed oil-rich supplementation for 2(P<0.05) and 4 
weeks(P<0.01). A significant difference in the generation of LTC4 was observed be- 
tween the two groups after different dietary supplementations for 4 weeks (P<0.05). 
Significantly increased values for PEF (P<0.01), FVC (P<0.05) and FEVl.o 
(P<0.05) were found in Group A subjects following perilla seed oil supplementation 
for 4 weeks, compared with the initial value prior to supplementation. 
A significant decrease in the serum level of total cholesterol, LDL-cholesterol and 
phospholipid was detected in Group A subjects following perilla seed oil 
supplementation for 4 weeks. The present results suggest that peril la seed oi l-rich 
supplementation is effective in the treatment of asthma in terms of its ability to 
suppress LTC4 generat ion by leucocytes, and in inducing an improvement in pulmonary 
function associated with changes in the serum level of lipids. 
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Introduction 
Bronchial allergen challenge induces both an 
immediate asthmatic reaction (IAR) within 
30 minutes and a late asthmatic reaction 
(LAR), which occurs 6-8 hours after the chal- 
lenge. The LAR, in which inflammatory cells 
such as lymphocytes, neutrophils, eosinophils 
and basophils migrate into sites of allergic 
reaction in the airway ", is closely associ- 
ated with bronchial hyperresponsiveness3. 4, . 
Leukotrienes (LTs), which are the major 
chemical mediators associated with asthma, 
and in particular LAR, are synthesized by 
inflammatory cells in large quantities during 
allergic reactions. 
LTs are generated from arachidonic acid 
(AA) through the 5-lipoxygenase pathway, 
and AA is in turn released from membrane 
phospholipids during cell activation5'. LTB4 
and LTC4 are generated from linoleic acid 
(LA) through AA, while LTB5 and LTC5 are 
generated from a -1inolenic acid ( a -LNA) 
through eicosapentaenoic acid (EPA) via the 
same 5-lipoxygenase pathway. Whereas LTB5 
has a much weaker action than LTB4, the 
action of LTC5 is approximately equivalent 
t o  that  of LTC4. 
Dietary supplementation with perilla seed 
oil, which is rich in a -LNA, is expected 
t o  suppress the generation of '&series' 
leukotrienes (LTB4 and LTC4) by leucocytes 
and t o  increase the generation of '5-series'- 
leukotrienes (LTB5 and LTC5). Conversely, 
supplementation with corn oil, which is  rich 
in LA, is expected to  increase the generation 
of '4-series' LTs, and t o  decrease the genera- 
tion of '5-series LTs' by leucocytes. In a pre- 
vious study6', we reported on the inhibitory 
effects on the generation of LTs by leucocytes 
of a diet containing perilla seed oil, a vegetable 
oil rich in a -LNA. 
The present study examined the effects of 
perilla seed oil-rich supplementation in con- 
trast t o  the effects of corn oil-rich supple- 
mentation in patients with asthma. 
Materials and Methods 
Subjects were 28 patients (8 men and 20 
wemen) admitted t o  our hospital t o  undergo 
treatment for asthma. The mean age of the 
patients was 61.1 years (range, 12 t o  84 
years) and the mean serum level of IgE was 
780.1IU/ml (range, 21.1 t o  6300 IU/ml). Of 
the 28 patients, 13 were atopic while the re- 
maining 15 were non- atopic. All subjects had 
moderate type asthma in severity. The mean 
duration of asthma was 13.6 years. All pa- 
tients were treated with long-acting oral theo- 
phylline, inhaled ,B 2 adrenergic agonists and 
inhaled glucocorticosteroid (beclomethasone 
dipropionate : BDP). The mean dose of in- 
haled BDP was 208.9yg/day. 
Asthma was evaluated according t o  the cri- 
teria of the International Consensus of Diag- 
nosis and Management of Asthma7'. All pa- 
tients showed reversible airway response, as  
indicated by a 15% or greater increase in 
their forced expiratory volume in one second 
(FEVI 01 after inhaled bronchodilator use. The 
study was approved by the Institutional Hu- 
man Investigation Committee of our hospital. 
Informed consent for the study protocol was 
obtained from all patients. 
Subjects were randomly divided into two 
goups : patients in Group A (15 subjects) 
consumed 10-20 grams of perilla seed oil per 
day as  salad dressing and/or mayonnaise in- 
stead of other oils for 4 weeks, while pa- 
tients in Group B (13 subjects) consumed an 
equivalent amount of corn oil per day for 4 
weeks. All other dietary components were 
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left unchanged, and the amount of oil used in 
the diet and supplemented diet were recorded 
throughout the study period. 
The concentration of serum total  choles- 
terol, triglyceride, high density lipoprotein 
(HDL)-cholesterol, and phospholipid were as- 
sayed using a previously reported enzymatic 
method8-"). Low density lipoprotein (LDL)- 
cholesterol concentration was calculated using 
the following formula : [(serum total  cholest- 
erol) - (HDL-cholesterol) -0.2 X (triglyceride)] 
(Friedwald's convert)'". ,6 -1ipoprotein was 
assayed by turbidimetry. Serum IgE levels 
were estimated using the radioimmunosorbent 
test (RIST) . 
Peak expiratory flow (PEF) in the early 
morning was recorded for all subjects using a 
peak flow meter (Assess : Health Scan Prod- 
ucts Inc. ,Cedar Grove, NJ, USA). Pulmonary 
function tests, forced vital capacity (FVC) 
and forced expiratory volume in one second 
(FEVI 0 )  were performed using a Chestac 33 
(Chest Co., Tokyo, Japan) linked t o  a com- 
puter a t  a point when patients were attack 
free. 
The generation of LTC4 by peripheral 
leucocytes was assessed using a previously 
described rnethodl3."). Cells were separated by 
counterflow centrifugation elutriation using a 
JE  6B rotor (Beckman Co., Geneva, Switzer- 
land)'" , as described previo~sly'~) . The num- 
ber of cells was then adjusted to  5X10"ml 
in Tris ACM (composition : lml  of O.lmol/ 
1Ca2+, 0.5ml of O.lmol/l Mg2+ and 98.5m1 
Tris A buffer ; Trizma preset crystal, pH 7.7 ; 
Sigma Chemical Co., St. Louis, MO, USA). 
The Ca ionophore, A23187 (1 p g) was added 
to  the cell suspension. The mixed solution 
was incubated for 15 min a t  37°C. Quanti- 
tation of LTC4 by HPLC analysis was per- 
formed using the method of Lam et  al.In . 
Extraction of LTs was performed using C18 
Seppak (Waters Associates, Milford MA). 
Concentrations of LTC4 were analyzed by the 
HPLC system Model 510 (Waters Associates, 
Milford, MA), equipped with an ultraviolet 
detector. The column used was a 5mm X lOcm 
Radial-Pax cartridge (Shimazu Co., Kyoto, 
Japan). The results were expressed a s  ng/5 
X 106cells. 
Data  were expressed as mean +SEM. Stu- 
dent's t-test was used for paired analysis. 
For group comparisons, we used one-way 
analysis of variance(AN0VA). P<0.05 was 
considered significant. Analyses were performed 
using StatView 5.0(Abacus Concepts, Inc., 
Berkeley, CA). 
Results 
The generation of LTC4 by leucocytes in 
Group A patients following perilla seed oil- 
rich supplementation showed a significant de- 
crease for 2(P<0.05) and 4 weeks(P<O.Ol). 
In contrast, LTC4 generation showed a ten- 
dency t o  increase in patients with corn oil- 
rich supplementation. Significantly increased 
LTC4 generation was found after 4-week corn 
oil supplementation. Furthermore, a signifi- 
cant difference in LTC4 generation was ob- 
served between the two groups a t  4 weeks 
(P<0.05) (Fig.1). 
PEF values in the morning increased in 
both two groups a t  4 weeks after dietary 
supplementation. A significant increase 
in PEF was observed at 2(P<0.05) and 
4 weeks (P<0.01) after perilla seed oil-rich 
supplementation. A significant increase was 
also found in patients with corn oil after  the 
4-week supplementation(P<0.05) (Table 1). 
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before after two weeks after four weeks 
Dietary supplementation 
Fig. 1. Changes in LTC4 generation in the 
two study groups. LTC4 generation 
decreased significantly after perilla 
seed oil-rich supplementation for 
two and four weeks (a). In con- 
trast ,  LTC4 generation increased af- 
ter corn oil-rich supplementation (0). 
A significant difference in LTC4 
generation was observed between the 
two study groups after different die- 
tary supplementations for 4 weeks. a 
and c : P<0.02 b : P<O.Ol. LTC4 : 
leukotriene C4 
Table. l. Comparison of morning PEF vzlues 
between groups 
PEF value (Umin) 
before after two weeks after four weeks 
GmupA 241.3f 1 3 4 . p  259.3f 113.9 271.3f 105.1b 
Gmup B 280.0f 102.45 309.1 f 113.7 318.2f 106.7 
FEVI. o after the Cweek corn oil-rich supple- 
mentation (Table 2). 
Table.2. Comparison of FCV and FEVI. o val- 
ues between groups 
Dietary supplementation 
before after four weeks 
- 
Gmup A 2.31 f 0.5@ 2.43f 0.40 
Gmup B 2.60f l . l 0  2.66f 1 . l 0  
Group A 1.45f 0.4$ 1.68f 0.51~ 
FEVlo(L1 
Gmup B 1.90f 0.91 1.87f 0.98 
In terms of lipid metabolism, the serum 
levels of to ta l  cholesterol, LDL- cholesterol 
and phospholipid decreased significantly in 
patients with perilla seed oil after the 4-week 
supplementation, but not in patients with 
corn oil-rich supplementation. The serum lev- 
els of triglyceride, HDL-Cholesterol, and .B - 
lipoprotein did not differ significantly be- 
tween groups after the dietary supplementa- 
tion (Table 3). 
Table.3. Comparison of the serum lipid level 
of between groups 
Dietary supplementation 
before after four weeks 
Group A 21 6.5k 39.5' 198.0i45.9 
Total Cholesterol(mg/d) 
Gmup 8 202.4k 38.5 189.3i39.9 
Gmup A 70.1 f 22.5 65.6f 22.1 
HDL-Cholesteroi(mg/di) 
Gmup 8 67.3k25.2 53.0f 13.9 
a and c:P<0.05. b:P<O.Ol 
Gmup A 152.0f 20.1~ 137.8f 24.$ 
LoL-Cholesterol(mg/dl) 
A significant increase in the value of FVC G ~ U P  B 139.1 i 25.4 125.7i 33.6 
was observed a t  4 weeks after perilla seed oil B-Lipopmtein(mg/dl) G ~ U P  A 428.6i 71.2 419.7k 76.8 
-rich supplementation (P<0.05). The FEV I.  o GNP B 464.ok55.2 462.7k108.6 
value also significantly increased a t  4 weeks Phwhollp,d(mg/dl) G ~ U P A  2 ~ 0 . 8 ~  19.p 216.4i 35.v 
after dietary supplementation with perilla ~ m u p  B zz3.7i 21.4 233.2k42.9 
seed oil (P<0.05). In contrast, no signifi- bandcP<0.05.a:P<O.O1 
cant increase was observed in either FVC or 
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Eosinophil counts in the two groups did 
not change significantly during the study pe- 
riod. 
Discussion 
Asthma is characterized by airway inflam- 
mation, bronchial hyper-responsiveness t o  non- 
specific stimuli, and episodic and reversible 
airflow obstruction. Airway inflammation is 
the main pathophysiological manifestation of 
asthma. Leukotrienes (LTs) are among the 
most important chemical mediators released 
from inflammatory cells, which are in turn 
involved in the pathogenesis of asthma. 
Generation of LTB4 is reportedly reduced 
by n-3 fa t ty  acids1819). In addition, LTB4 gen- 
erated from LA and LTBS from a-LNA have 
similar biological activities. However, LTBS 
has a much weaker action than LTB4. 
Cysteinyl LTs (LTC4, LTD4 and LTE4) are 
implicated in the pathogenesis of allergen-in- 
duced airway responses as potent contractile 
agonists for airway smooth muscle1. l" . 
Moreover, they mediate at a latter  stage of 
immediate airway obstruction, namely a fall 
in FEV l after allergen exposurem 'l). 
Polyunsaturated fa t ty  acids (PUFAs) of 
the n-3 series[EPA and docosahexaenoic acid 
(DHA)] suppress the production of LTs by 
antagonistic metabolism, which occurs a t  the 
level of LT hydrolase through the 5-lipoxy- 
genase pathway. Therefore, PUFAs may po- 
tentially alter LT generation by leucocytesn). 
The above PUFAs have been reported to  show 
anti-inflammatory effects in patients with 
chronic inflammatory diseases such as rheu- 
matoid arthritis, psoriasis, and chronic in- 
flammatory bowel d i s e a ~ e ~ - ' ~ .  Several stud- 
ies have focused on the beneficial effects of 
EPA or fish oil on bronchial a ~ t h m a ~ - ~ .  
In the present study, the effects of a-LNA 
rich perilla seed oil on asthma were compared 
with the effects of LA-enriched corn oil. The 
results revealed that  a -LNA-rich perilla seed 
oil supplementation significantly suppressed 
the generation of LTC4. Furthermore, sub- 
jects given perilla seed oil-rich supplemen- 
tation showed significantly higher increases 
in PEF, FVC, and FEVl 0 levels after the 4- 
week dietary supple-mentation. However, 
both groups showed an increase in PEF val- 
ues during the study period. This was con- 
cluded to  be due t o  other therapies(drugs and 
respiratory rehabilitation) that  accompanied 
the diet therapy. 
Several reports have failed to  detect any 
beneficial effect of EPA in patients with 
bronchial asthmax m. The present study dem- 
onstrated the efficacy of perilla seed oil in 
treating asthma. Perilla seed oil is metabo- 
lized t o  form EPA. Therefore, the action of 
perilla seed oil might include not only the 
effects of perilla seed oil itself but that  of 
EPA as  well. The present study did not ex- 
amine changes in the serum IgE value, nor 
did i t  examine the n-3 fa t ty  acids/n-6 fa t ty  
acids ratio. Some reports have documented a 
significant influence of dietary PUFA on the 
serum IgE and n-3 fa t ty  acids/n-6 fa t ty  acids 
ratio" ". 
Previous reports have suggested that PUFAs 
diets that  include a -LNA - decrease serum 
lipids3-*l. In particular, some studies have 
reported that  perilla seed oil-rich supple- 
mentation decreased serum lipids inrats6*). 
Recent dietary supplementation trends in Ja-  
pan have included a high consumption of 
saturated fa t ty  acids and n-6 PUFAs and low 
n-3 PUFAsdn. The present study findings re- 
vealed that  perilla seed oil-rich supplemen- 
tation decreased serum levels of total  choles- 
terol, LDL-cholesterol and phospholipid. 
55 Effects of n-3 fa t ty  acids on asthma and shanges in lipids 
The present study findings suggested tha t  
dietary supplementation with perilla seed oil, 
rich in a-LNA, was significantly more bene- 
ficial for asthma than that  with corn oil, 
rich in LA, in terms of i t s  suppressive effect 
on the generation of LTs by leucocytes asso- 
ciated with lipometabolism. 
The present study may represent an impor- 
tant  step in the development of a diet ther- 
apy for asthmatic patients. Future studies 
are needed t o  further develop a nutritionally 
balanced diet therapy for asthma. 
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脂肪の変化と関連した気管支喘息に対する．n－3系  
脂肪酸食の効果－n－6系脂肪酸との比較  
岡本 誠，光延文裕，芦田耕三，御船尚志，  
保崎泰弘，柘野浩史，高田真吾，谷崎勝朗，  
原田実根1）  
岡山大学三朝分院内科大学医学部附属病院三朝分  
院内科l）岡山大学第二内科  
n－3系脂肪酸は喘息に有効であることが報告さ  
れている。今回、エゴマ油（n－3系脂肪酸）の喘  
息に対する効果を呼吸機能、 
イコトリエンC4（LTC4）産生能の観点から、  
コーン油（n－6系脂肪酸）のそれと比較した。28  
例の喘息患者を無作為に2群に分け、A群（15例）  
はエゴマ油食を、B群（13例）はコーン油食をそ  
れぞれ4週間摂取した。白血球LTC4産生能、呼  
吸機能、血清脂質を2群間で比較した。白血球  
LTC4産生能はエゴマ抽食を摂取したA群で2週  
後（P＜0．05）、4過後（P＜0．01）に有意に低下した。  
食事摂取4過後に岳群間でLTC4産生能に有意差  
が認められた（P＜0．05）。エゴマ油食を4過摂取し  
たA群ではピークフロー（P＜0．05）、肺活量（P＜  
0．01）、1秒量（P＜0．05）が食事摂取前に比し、有  
意に増加した。またA群ではエゴマ坤食摂取4週  
後に血清総コレステロール値、LDL－コレステ  
ロール値、リン脂質の有意な低下がみられた。こ  
れらの結果より、エゴマ油食は白血球LTC4産  
生能を抑制することにより、呼吸機能を改善し、  
血清脂質の変化と関連して、喘息の治療に有効で  
あることが示唆された。 
牽引用語：ェゴマ抽、α－リノレン酸、ロイコト  
リエンC4，呼吸機能、脂質代謝   
